The Latest Breaking News on Pharma

There's a large pipeline of promising yet expensive drugs that could get approved.

New hire brings more than 30 years worth of biotech industry experience

Pharmacies are struggling to get hold of cough and cold medicines

BioNTech SE has signed a deal with the UK government to enrol up to 10,000 patients in clinical trials by the end of 2030 for personalised cancer therapies, the German drug maker said.

Inverness-based medical technology firm ran out of funds and appointed administrators just before Christmas

With encouraging economic data discouraging investors, the market is unlikely to stabilize anytime soon. Therefore, loading up on fundamentally strong stocks AbbVie (ABBV), Gartner (IT), and Dropbox (DBX) could keep portfolios buoyant and generate alpha in an otherwise chronic bear market. Continue reading….

Once certified, the two largest national pharmacy chains will be able to prescribe mifepristone, a pill used in medication abortions.

Amid rapidly declining health, thalidomide survivors are still waiting for a national apology after a drug that caused catastrophic birth deformities in unborn babies continued to be sold in pharmacies.

Lawyers representing Health and Social Care Secretary Steve Barclay have outlined detail of a High Court claim against PPE Medpro.

United Therapeutics is the IBD Stock Of The Day as competition heats up in its lung disease market. UTHR stock is eyeing two potential buy points.

A warning has been issued by health chiefs with regards to low supplies of common cold and flu medicines, while pharmacists struggle to stock up on Calpol, certain painkillers and throat lozenges